<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Classification of acute and chronic lower extremity ischemia</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Classification of acute and chronic lower extremity ischemia</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Classification of acute and chronic lower extremity ischemia</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Joseph L Mills, Sr, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">John F Eidt, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Kathryn A Collins, MD, PhD, FACS</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Feb 17, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H909629103"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>When selecting treatment options for lower extremity revascularization, the risks of a given intervention relative to the patient's medical condition must be weighed against the urgency and severity of the threat to limb, the expected improvement in the patient's clinical condition (eg, pain relief, ulcer healing, maintenance of ambulatory and functional status) and the durability of the intervention in the context of the patient's life expectancy [<a href="#rid1">1</a>]. Grading the symptoms of ischemia and the anatomic lesions responsible for these symptoms provides objective measures by which to follow patients clinically, and, importantly, provides consistency when comparing medical and interventional treatment strategies in clinical studies. For patients who suffer from symptoms related to peripheral artery disease (PAD), impairment and disability may need to be quantified for insurance purposes, or in order to qualify for a disability program.</p><p>Classification schemes that are useful in guiding management of acute and chronic lower extremity ischemia are reviewed here. The clinical diagnosis and treatment of peripheral artery disease presenting with claudication or chronic limb-threatening ischemia are discussed elsewhere. (See  <a class="medical medical_review" href="/z/d/html/8208.html" rel="external">"Clinical features and diagnosis of lower extremity peripheral artery disease"</a> and  <a class="medical medical_review" href="/z/d/html/8210.html" rel="external">"Management of claudication due to peripheral artery disease"</a> and  <a class="medical medical_review" href="/z/d/html/8215.html" rel="external">"Management of chronic limb-threatening ischemia"</a> and  <a class="medical medical_review" href="/z/d/html/15217.html" rel="external">"Endovascular techniques for lower extremity revascularization"</a> and  <a class="medical medical_review" href="/z/d/html/15194.html" rel="external">"Lower extremity surgical bypass techniques"</a>.)</p><p class="headingAnchor" id="H909629146"><span class="h1">LOWER EXTREMITY ANATOMY</span><span class="headingEndMark"> — </span>Knowledge of lower extremity arterial anatomy is important for understanding both acute and chronic lower extremity ischemia.</p><p>The lower extremity is perfused by the common femoral artery  (<a class="graphic graphic_figure graphicRef51298" href="/z/d/graphic/51298.html" rel="external">figure 1</a>). The common femoral artery branches into the superficial and deep femoral arteries a short distance inferior to the inguinal ligament. The superficial femoral artery runs anteriorly down the thigh between the adductor and quadriceps muscles within the anterior compartment  (<a class="graphic graphic_figure graphicRef72956" href="/z/d/graphic/72956.html" rel="external">figure 2</a>). In the distal third of the thigh, the superficial femoral artery is in close proximity to the femur. The superficial femoral artery passes through the adductor canal to become the popliteal artery  (<a class="graphic graphic_picture graphicRef77245" href="/z/d/graphic/77245.html" rel="external">picture 1</a>), which most commonly divides at the level of the tibial tuberosity into the anterior tibial artery and tibioperoneal trunk, which further divides into the posterior tibial and peroneal arteries  (<a class="graphic graphic_figure graphicRef54800 graphicRef65590" href="/z/d/graphic/54800.html" rel="external">figure 3A-B</a>). The anterior tibial artery accompanies the deep peroneal (fibular) nerve along the posterior margin of the tibia  (<a class="graphic graphic_figure graphicRef68629" href="/z/d/graphic/68629.html" rel="external">figure 4</a>). The peroneal artery passes adjacent to the medial margin of the fibula throughout its course distally. The posterior tibial artery is accompanied by the tibial nerve within the deep posterior compartment. </p><p>The collateral circulation in the lower extremity is derived from the deep femoral artery (profunda femoris)  (<a class="graphic graphic_figure graphicRef72956" href="/z/d/graphic/72956.html" rel="external">figure 2</a>). Collaterals are poorly developed in younger patients, who thus tend to develop severe acute ischemia with disruption of arterial continuity at the femoral or popliteal levels. </p><p class="headingAnchor" id="H1576665376"><span class="h1">ANATOMIC LESION CLASSIFICATIONS</span></p><p class="headingAnchor" id="H2691165807"><span class="h2">GLASS classification</span><span class="headingEndMark"> — </span>The Global Limb Anatomic Staging System (GLASS) is an anatomic scheme proposed in the 2019 global vascular guidelines on the management of chronic limb-threatening ischemia (CLTI) [<a href="#rid2">2</a>]. The GLASS classification stratifies anatomic severity and provides a framework for evidence-based lower extremity revascularization of CLTI. More specifically, GLASS involves grading the level of disease in the femoropopliteal and infrapopliteal segments of the preferred target arterial path for revascularization  (<a class="graphic graphic_table graphicRef119060" href="/z/d/graphic/119060.html" rel="external">table 1</a>), and these are combined to provide an anatomic stage (I to III) of overall complexity that is intended to estimate limb-based patency of lower extremity interventions for CLTI. </p><p class="headingAnchor" id="H909629056"><span class="h2">TASC classification</span><span class="headingEndMark"> — </span>Arterial lesions can be classified by Trans-Atlantic Inter-Society Consensus (TASC II) as Type A, B, C, or D according to anatomic distribution, number and nature of lesions (stenosis, occlusion), and according to the overall success rates of treating the lesion using endovascular or surgical means [<a href="#rid1">1</a>]. In general, short segments of disease are more likely to be successfully and durably treated with an endovascular intervention compared with longer, occluded and heavily calcified segments; such considerations form the basis of the classification. However, most patients with peripheral artery disease have more than one lesion, at more than one level, so this classification scheme is limited in focusing on diseased segments rather than the entire limb. Scoring systems that take into account multifocal disease have been used predominantly in research studies [<a href="#rid3">3,4</a>]. (See <a class="local">'Bollinger scoring method'</a> below.)</p><p>The original TASC I classification included classifications for aortoiliac, femoropopliteal, and tibial vessel runoff. Tibial disease was omitted from TASC II. A new tibial classification system has been proposed by selected former TASC steering committee members; this proposed system considers tibial stenosis length, lesion number, presence of occlusion, density of calcification, and nonvisualization of collaterals [<a href="#rid5">5,6</a>]. However, this tibial classification system is not widely used and has not yet been validated. </p><p class="headingAnchor" id="H909629063"><span class="h3">Type A lesions</span><span class="headingEndMark"> — </span>Type A lesions are relatively short and focal, and generally have excellent results with endovascular therapy.</p><p class="bulletIndent1"><span class="glyph">●</span>Aortoiliac – Unilateral or bilateral stenosis of the common iliac artery; unilateral or bilateral single short (≤3 cm) stenosis of the external iliac artery</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Femoropopliteal – Single stenosis ≤10 cm in length; single occlusion ≤5 cm in length</p><p></p><p class="headingAnchor" id="H909629070"><span class="h3">Type B lesions</span><span class="headingEndMark"> — </span>Type B lesions have good results using endovascular methods, which are preferred, unless open revascularization is required for another lesion in the same anatomic area.</p><p class="bulletIndent1"><span class="glyph">●</span>Aortoiliac – Short (≤3 cm) stenosis of the infrarenal aorta; unilateral common iliac artery occlusion; single or multiple stenoses totaling 3 to 10 cm in length of the external iliac artery not extending into the common femoral artery; unilateral external iliac artery occlusion not involving the origins of the internal iliac artery or common femoral artery</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Femoropopliteal – Multiple lesions (stenoses or occlusions), each ≤5 cm; stenosis or occlusion ≤15 cm not involving the infra-geniculate popliteal artery; single or multiple lesions in the absence of continuous tibial vessels to improve inflow for a distal bypass; heavily calcified occlusion ≤5 cm in length; single popliteal stenosis</p><p></p><p class="headingAnchor" id="H909629077"><span class="h3">Type C lesions</span><span class="headingEndMark"> — </span>Type C lesions may have better long-term results with open revascularization such that endovascular techniques should be used if the patient is at high risk for open surgical repair.</p><p class="bulletIndent1"><span class="glyph">●</span>Aortoiliac – Bilateral common iliac artery occlusions; bilateral external iliac artery stenosis 3 to 10 cm not extending into the common femoral artery; unilateral external iliac artery stenosis extending into the common femoral artery; unilateral external iliac artery occlusion of the origins of the internal iliac and/or common femoral artery; heavily calcified unilateral external iliac artery occlusion with or without involvement of the origins of the internal iliac and/or common femoral artery</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Femoropopliteal – Multiple stenoses or occlusion totaling &gt;15 cm with or without heavy calcification; recurrent stenoses or occlusion that need treatment after two endovascular interventions</p><p></p><p class="headingAnchor" id="H909629084"><span class="h3">Type D lesions</span><span class="headingEndMark"> — </span>Type D lesions have poorer results with endovascular treatment, and thus, surgery is the primary treatment for low-to-moderate risk patients. However, reasonable results can be obtained for type D iliac lesions with a hybrid approach that combines open femoral endarterectomy with patch closure and retrograde iliac stenting in this setting.</p><p class="bulletIndent1"><span class="glyph">●</span>Aortoiliac – Infrarenal aortoiliac occlusion; diffuse disease of the aorta and both iliac arteries requiring treatment; diffuse multiple stenoses of the unilateral common and iliac artery, and common femoral artery; unilateral occlusions of the common iliac and external iliac arteries; bilateral occlusions of external iliac arteries; iliac stenoses in patients with abdominal aortic aneurysm (that require treatment and are not amenable to endograft placement) or other lesions requiring open aortic or iliac surgery.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Femoropopliteal – Chronic total occlusion of the common femoral artery or superficial femoral artery (&gt;20 cm, involving the popliteal artery); chronic total occlusion of the popliteal artery and proximal trifurcation vessels.</p><p></p><p class="headingAnchor" id="H1576665412"><span class="h2">Bollinger scoring method</span><span class="headingEndMark"> — </span>For the Bollinger method, 13 infrainguinal arterial segments are assessed, and each of these segments is scored according to the severity and extent of disease [<a href="#rid4">4,7</a>]. Four lesion severities are characterized. To calculate the additive scores, the individual scores for each of the lesion severities are summed in accordance with the following rules: in the presence of occlusions, stenoses and plaques are not considered; when both severities of stenoses are present (ie, ≥50 percent and ≤50 percent), plaques are not scored; for each type of occlusive lesion, only one length category is indicated. The scoring system is somewhat complex and given in figure 2 of the associated reference [<a href="#rid7">7</a>].</p><p>Arterial segments:</p><p class="bulletIndent1"><span class="glyph">●</span>Profunda femoris artery</p><p class="bulletIndent1"><span class="glyph">●</span>Proximal (upper half) superficial femoral artery</p><p class="bulletIndent1"><span class="glyph">●</span>Distal (lower half) superficial femoral artery</p><p class="bulletIndent1"><span class="glyph">●</span>Above-knee popliteal artery</p><p class="bulletIndent1"><span class="glyph">●</span>Below-knee popliteal artery</p><p class="bulletIndent1"><span class="glyph">●</span>Tibioperoneal trunk </p><p class="bulletIndent1"><span class="glyph">●</span>Proximal (upper-half calf) posterior tibial artery</p><p class="bulletIndent1"><span class="glyph">●</span>Distal (lower-half calf) posterior tibial artery</p><p class="bulletIndent1"><span class="glyph">●</span>Proximal (upper-half) anterior tibial artery </p><p class="bulletIndent1"><span class="glyph">●</span>Distal (lower-half) anterior tibial artery </p><p class="bulletIndent1"><span class="glyph">●</span>Proximal (upper-half) peroneal artery</p><p class="bulletIndent1"><span class="glyph">●</span>Distal (lower-half) peroneal artery </p><p class="bulletIndent1"><span class="glyph">●</span>Plantar arch</p><p></p><p>Lesion severity described as:</p><p class="bulletIndent1"><span class="glyph">●</span>Occlusion of the lumen</p><p class="bulletIndent1"><span class="glyph">●</span>Stenoses that are more than one-half the luminal diameter (ie, &gt;50 percent)</p><p class="bulletIndent1"><span class="glyph">●</span>Stenoses narrowing the lumen by more than 25 percent, but maximally 50 percent</p><p class="bulletIndent1"><span class="glyph">●</span>Plaques producing stenosis of the artery by no more than 25 percent</p><p></p><p>Lesion extent described as:</p><p class="bulletIndent1"><span class="glyph">●</span>Single lesion</p><p class="bulletIndent1"><span class="glyph">●</span>Multiple lesions affecting less than one-half of the segment</p><p class="bulletIndent1"><span class="glyph">●</span>Multiple lesions affecting more than one-half of the segment</p><p></p><p class="headingAnchor" id="H1576665923"><span class="h2">Graziani morphologic classification</span><span class="headingEndMark"> — </span>The Graziani morphologic classification refers to a system for defining arterial lesions in patients with diabetes with progressively increasing extent of arterial involvement [<a href="#rid8">8,9</a>].</p><p class="bulletIndent1"><span class="glyph">●</span>Class 1 – Isolated, one vessel tibial or peroneal artery obstruction</p><p class="bulletIndent1"><span class="glyph">●</span>Class 2a – Isolated femoral/popliteal artery or two below-knee arteries obstructed but with patency of one of the two tibial arteries</p><p class="bulletIndent1"><span class="glyph">●</span>Class 2b – Isolated femoral/popliteal artery or two below-knee tibial arteries obstructed but with patency of the peroneal artery</p><p class="bulletIndent1"><span class="glyph">●</span>Class 3 – Isolated, one artery occluded and multiple stenoses of tibial/peroneal and/or femoral/popliteal arteries</p><p class="bulletIndent1"><span class="glyph">●</span>Class 4 – Two arteries occluded and multiple stenoses of tibial/peroneal and/or femoral/popliteal vessels</p><p class="bulletIndent1"><span class="glyph">●</span>Class 5 – Occlusion of all tibial and peroneal arteries (below-knee cross-sectional occlusion)</p><p class="bulletIndent1"><span class="glyph">●</span>Class 6 – Three arteries occluded and multiple stenoses of tibial/peroneal and/or femoral/popliteal arteries</p><p class="bulletIndent1"><span class="glyph">●</span>Class 7 – Multiple femoropopliteal obstructions with no visible below-the-knee arterial segments</p><p></p><p class="headingAnchor" id="H1576665352"><span class="h1">SYMPTOM CLASSIFICATION</span></p><p class="headingAnchor" id="H1576666175"><span class="h2">Chronic extremity ischemia</span><span class="headingEndMark"> — </span>Patients with chronic lower extremity ischemia present with symptoms of peripheral artery disease that can include rest pain, which is pain across the base of the metatarsal heads and forefoot at rest and with recumbency relieved by dependency, or with tissue loss, which can be ulceration, dry gangrene, or wet gangrene. The Rutherford and Fontaine symptom classification systems were the most widely used classification systems for decades [<a href="#rid10">10,11</a>]. The walking impairment that defines mild, moderate, and severe claudication is specified by performance on five-minute treadmill test at 2 mph on a 12 percent incline in the Rutherford classification, and as part of the Fontaine classification is specified as 650 feet (200 meters).</p><p class="headingAnchor" id="H1576665360"><span class="h3">Rutherford</span></p><p class="bulletIndent1"><span class="glyph">●</span>Stage 0 – Asymptomatic</p><p class="bulletIndent1"><span class="glyph">●</span>Stage 1 – Mild claudication</p><p class="bulletIndent1"><span class="glyph">●</span>Stage 2 – Moderate claudication </p><p class="bulletIndent1"><span class="glyph">●</span>Stage 3 – Severe claudication</p><p class="bulletIndent1"><span class="glyph">●</span>Stage 4 – Rest pain</p><p class="bulletIndent1"><span class="glyph">●</span>Stage 5 – Minor tissue loss with ischemic nonhealing ulcer or focal gangrene with diffuse pedal ischemia</p><p class="bulletIndent1"><span class="glyph">●</span>Stage 6 – Major tissue loss – Extending above transmetatarsal level, functional foot no longer salvageable</p><p></p><p class="headingAnchor" id="H1576665368"><span class="h3">Fontaine</span></p><p class="bulletIndent1"><span class="glyph">●</span>Stage 1 – No symptoms</p><p class="bulletIndent1"><span class="glyph">●</span>Stage 2 – Intermittent claudication subdivided into:</p><p class="bulletIndent1"><span class="glyph">●</span>Stage 2a – Without pain on resting, but with claudication at a distance of greater than 650 feet (200 meters)</p><p class="bulletIndent1"><span class="glyph">●</span>Stage 2b – Without pain on resting, but with a claudication distance of less than 650 feet (200 meters)</p><p class="bulletIndent1"><span class="glyph">●</span>Stage 3 – Nocturnal and/or resting pain</p><p class="bulletIndent1"><span class="glyph">●</span>Stage 4 – Necrosis (death of tissue) and/or gangrene in the limb</p><p></p><p class="headingAnchor" id="H465130934"><span class="h3">WIfI (Wound, Ischemia, foot Infection)</span><span class="headingEndMark"> — </span>The Society for Vascular Surgery (SVS) Lower Extremity Threatened Limb Classification System, Wound, Ischemia, foot Infection (WIfI), is an updated system for classifying the severity of limb threat that is intended to more accurately reflect important clinical considerations that impact management and amputation risk, and also to permit more meaningful analysis of outcomes for various forms of therapy [<a href="#rid12">12</a>]. The global vascular guidelines for the management of chronic limb-threatening ischemia (CLTI) recommend staging the limb using WIfI [<a href="#rid2">2</a>]. The WIfI threatened limb classification has been validated in multiple studies and provides a pragmatic means to assess the likelihood of wound healing and amputation risk in patients with a spectrum of CLTI [<a href="#rid13">13-19</a>]. The WIfI classification, with a calculator, is presented briefly below; the complete classification is available as an open access document from the SVS on the Journal of Vascular Surgery website [<a href="#rid20">20</a>], and as an Interactive Practice Guideline (iPG) app [<a href="#rid21">21</a>].</p><p>The Rutherford and Fontaine classifications, which are decades old, were designed to classify chronic limb ischemia among patients with pure ischemia due to peripheral artery disease (PAD). However, due to marked demographic shifts, particularly a dramatic rise in diabetes prevalence, these classifications are less useful for appropriately classifying patients with diabetes, neuropathy, or an index wound with or without infection, across a broader spectrum of PAD severity. In such patients, limb perfusion is only one determinant of outcome. Wound extent and infection also significantly impact the threat to a limb. The classification can be visualized as three intersecting rings of risk  (<a class="graphic graphic_figure graphicRef103041" href="/z/d/graphic/103041.html" rel="external">figure 5</a>) [<a href="#rid17">17,22</a>]. WIfI also helps identify which of these risks is "dominant" at a given point in time throughout the patient's life. </p><p>WIfI grades each of three factors on a scale from 0 to 3: the wound, the severity of ischemia, and the presence and severity of foot infection. The 64 resulting potential combinations of grades were placed (by Delphi consensus) into one of four clinical stages (1 through 4) that correlate with the potential for wound healing and risk of major limb amputation at one year  (<a class="graphic graphic_table graphicRef127211" href="/z/d/graphic/127211.html" rel="external">table 2</a>). Clinical stage 1 limbs rarely require revascularization and can usually be healed with simple wound care and offloading. By contrast, patients with clinical stage 4 limbs have very high amputation risk. Clinical stages 2 and 3 are intermediate in threat to the limb. It is important to remember that the <strong>stage </strong>of limb threat, not the individual grades of wound, ischemia, or infection, drive urgency and potential need for admission and revascularization.</p><p class="bulletIndent1"><span class="glyph">●</span>Wound: </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Grade 0 – Rest pain; no wound, no ulcer, no gangrene.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Grade 1 – Small shallow ulcer(s) on distal leg or foot, any exposed bone is only limited to distal phalanx; no gangrene, or gangrene limited to distal toe (ie, minor tissue loss: limb salvage possible with no more than simple digital amputation [1 or 2 digits], or skin coverage). </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Grade 2 – Deeper ulcer on distal leg or foot with exposed bone, joint, or tendon, or shallow heel ulcer without involvement of the calcaneus; gangrenous changes confined to the digits (ie, major tissue loss: salvageable with ≥3 digital amputations or standard transmetatarsal amputation [TMA] plus skin coverage).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Grade 3 – Extensive deep ulcer of the forefoot and/or midfoot, or full-thickness heel ulcer with or without involvement of the calcaneus (ie, extensive tissue loss: salvageable only with complex foot reconstruction or nontraditional TMA [eg, Chopart or Lisfranc amputation]).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Ischemia (note that toe systolic pressures are preferred in patients with diabetes):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Grade 0 – ABI ≥0.8, ankle systolic pressure &gt;100 mmHg, toe pressure (TP)/transcutaneous oxygen (TcPO<sub>2</sub>) ≥60.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Grade 1 – ABI 0.6 to 0.79, ankle systolic pressure 70 to 100 mmHg, TP/TcPO<sub>2</sub> 40 to 59.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Grade 2 – ABI 0.4 to 0.59, ankle systolic pressure 50 to 70 mmHg, TP/TcPO<sub>2</sub> 30 to 39.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Grade 3 – ABI ≤0.39, ankle systolic pressure &lt;50 mmHg, TP/TcPO<sub>2</sub> &lt;30.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Foot infection</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Grade 0 – No symptoms or signs of infection.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Grade 1 – Infection is present and at least two of the following are present: local swelling or induration, erythema &gt;0.5 to ≤2 cm around ulcer, local tenderness or pain, local warmth, or purulent discharge. Other causes of an inflammatory response of the skin have been excluded (eg, gout, fracture).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Grade 2 – Local infection is present as defined for Grade 1 but extends &gt;2 cm around ulcer or involves structures deeper than the skin and subcutaneous tissues (eg, abscess, osteomyelitis, septic arthritis, fasciitis). No clinical signs of systemic inflammatory response.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Grade 3 – Local infection is present as defined for Grade 2, but clinical signs of systemic inflammatory response are present as manifested by two or more of the following: temperature &gt;38°C or &lt;36°C; heart rate &gt;90 beats per minute, respiratory rate &gt;20 breaths per minute or PaCO<sub>2</sub> &lt;32 mmHg; white blood cell count &gt;12,000 or &lt;4000 (cu/mm) or &gt;10 percent immature band forms present.</p><p></p><p>The system is not intended to dictate treatment but rather to more precisely stratify patients according to their initial disease burden in a manner that is analogous to Tumor-Nodes-Metastasis (TNM) staging for cancer. WIfI stages at presentation have correlated strongly with wound healing time and wound healing rate at one year [<a href="#rid23">23-27</a>]. The use of WIfI to stratify amputation risk has been reported from multiple centers across the United States and from France, Italy, Germany, Spain, and Japan [<a href="#rid23">23,28,29</a>]. In a systematic review and meta-analysis of WIfI staging for CLTI, estimated one-year major amputation rates (569 patients from four studies) for WIfI stages 1 to 4 were 0 percent, 8 percent (95% CI 3-21), 11 percent (95% CI 6-18), and 38 percent (95% CI 21-58), respectively. The likelihood of an amputation after one year was increased for patients with CLTI and higher WIfI stages, which is important prognostic information [<a href="#rid13">13</a>]. Two publications suggest that WIfI clinical stage 4 patients have a very low wound healing rate (44 percent) and high reintervention rate (46 percent) after endovascular therapy [<a href="#rid24">24</a>]. In one of these, a prospective cohort study, freedom from major limb amputation was superior for clinical stage 4 patients who underwent bypass compared to those who underwent endovascular therapy. If these results can be confirmed prospectively, WIfI may prove to be a useful tool to aid in the selection of endovascular therapy or open bypass in patients with CLTI [<a href="#rid28">28</a>]. </p><p>The WIfI system was also intended to be used for restaging after therapy, much as TNM is used when treating cancer. In other studies, wound, ischemia, and infection grades at one and six months correlated highly with amputation-free survival (AFS) and suggested that serial WIfI staging and restaging identifies a cohort at especially high risk of amputation who may merit timely reintervention [<a href="#rid28">28,29</a>]. WIfI stages have also been reported to correlate with costs of care [<a href="#rid28">28,30</a>]. WIfI also allows comparison of therapeutic alternatives among patients with threatened limbs who have a similar risk for amputation. </p><p class="headingAnchor" id="H909633906"><span class="h2">Acute extremity ischemia</span><span class="headingEndMark"> — </span>Acute limb ischemia is defined as a sudden decrease in limb perfusion that causes a potential threat to limb viability in patients who present within two weeks of the acute event [<a href="#rid1">1</a>]. The SVS/ISCVS (Rutherford) classification stratifies limb ischemia based upon the presence and degree of sensorimotor deficits and Doppler findings [<a href="#rid10">10,31-33</a>]. There are numerous etiologies, including but not limited to cardiogenic or arteriogenic emboli, thrombosis of an existing aneurysm (eg, popliteal artery), occlusion of a previously placed bypass graft or stent, and thrombosis at the site of preexisting atherosclerotic disease (adductor canal SFA stenosis). (See  <a class="medical medical_review" href="/z/d/html/8213.html" rel="external">"Clinical features and diagnosis of acute lower extremity ischemia", section on 'Etiologies'</a>.) </p><p class="headingAnchor" id="H909634102"><span class="h3">Viable (I)</span><span class="headingEndMark"> — </span>Viable limbs are under no immediate threat of tissue loss. There is no sensory loss or muscle weakness, and both arterial and venous Doppler signals are audible.</p><p class="headingAnchor" id="H909634109"><span class="h3">Marginally threatened (IIa)</span><span class="headingEndMark"> — </span>Marginally threatened limbs are salvageable if treated promptly. There is minimal pain and minimal (toes only) or no sensory loss, and no muscle weakness; arterial Doppler signals are often inaudible, but venous Doppler signals are audible.</p><p class="headingAnchor" id="H909634116"><span class="h3">Immediately threatened (IIb)</span><span class="headingEndMark"> — </span>Immediately threatened limbs are salvageable with immediate revascularization. Sensory loss involves more than the toes and may be associated with rest pain in the foot (not just confined to toes). There is mild-to-moderate muscle weakness, arterial Doppler signals are usually inaudible, and venous Doppler signals are audible.</p><p class="headingAnchor" id="H909634123"><span class="h3">Irreversible (III)</span><span class="headingEndMark"> — </span>Irreversible ischemic (nonviable) limbs have a severe and permanent nerve deficit. Sensory loss is profound, muscle weakness is profound with paralysis and possible rigor, and arterial and venous Doppler signals are inaudible. These nonviable extremities require major amputation regardless of the therapy that is instituted. Revascularization may be required to permit healing of the amputation or to lower the level of amputation needed.</p><p class="headingAnchor" id="H909629720"><span class="h1">LOWER EXTREMITY IMPAIRMENT</span><span class="headingEndMark"> — </span>Vascular disease impairs the individual's ability to function in society. The American Medical Association (AMA) lower extremity impairment grading scale defines increasing degrees of disability based upon clinical features [<a href="#rid34">34-36</a>]. The AMA scale includes symptoms and signs primarily related to peripheral artery disease but also includes chronic venous disease. The elements of this scale that pertain to peripheral artery disease are included below. We prefer to use validated scales for venous disability, which are presented separately. (See  <a class="medical medical_review" href="/z/d/html/8177.html" rel="external">"Classification of lower extremity chronic venous disorders", section on 'Venous disability score'</a>.)</p><p class="headingAnchor" id="H909629728"><span class="h2">Class 0</span><span class="headingEndMark"> — </span>(Whole person impairment [WPI]: 0 percent.) The patient does not have claudication or pain at rest or the patient experiences only transient edema, but one of the following physical examination findings is present: </p><p class="bulletIndent1"><span class="glyph">●</span>Loss of pulses </p><p class="bulletIndent1"><span class="glyph">●</span>Minimal loss of subcutaneous tissue </p><p class="bulletIndent1"><span class="glyph">●</span>Calcification of arteries detected on radiographic examination </p><p class="bulletIndent1"><span class="glyph">●</span>Asymptomatic stenosis of arteries not requiring surgery and not resulting in curtailment of activities </p><p></p><p class="headingAnchor" id="H909629742"><span class="h2">Class 1</span><span class="headingEndMark"> — </span>(WPI: 2 to 10 percent.) The patient has at least one of the following:</p><p class="bulletIndent1"><span class="glyph">●</span>Intermittent claudication is present on walking at least 100 yards at an average pace</p><p class="bulletIndent1"><span class="glyph">●</span>Evidence of tissue damage such as healed stump (single amputated digit) or a healed ulceration</p><p></p><p class="headingAnchor" id="H909629735"><span class="h2">Class 2</span><span class="headingEndMark"> — </span>(WPI: 11 to 23 percent.) The patient has at least one of the following:</p><p class="bulletIndent1"><span class="glyph">●</span>Intermittent claudication on walking as few as 25 yards and no more than 100 yards at average pace</p><p class="bulletIndent1"><span class="glyph">●</span>Evidence of tissue damage such as healed amputations (two or more digits in one extremity) with evidence of superficial ulceration</p><p></p><p class="headingAnchor" id="H909629757"><span class="h2">Class 3</span><span class="headingEndMark"> — </span>(WPI: 25 to 40 percent.) The patient has at least one of the following:</p><p class="bulletIndent1"><span class="glyph">●</span>The patient experiences intermittent claudication on walking less than 25 yards</p><p class="bulletIndent1"><span class="glyph">●</span>The patient experiences intermittent pain at rest</p><p class="bulletIndent1"><span class="glyph">●</span>Evidence of vascular damage such as amputation at or above an ankle of one extremity, or amputation of two or more digits of two extremities with persistent vascular disease with persistent widespread or deep ulceration involving one extremity</p><p></p><p class="headingAnchor" id="H909629764"><span class="h2">Class 4</span><span class="headingEndMark"> — </span>(WPI: 45 to 65 percent.) The patient has at least one of the following:</p><p class="bulletIndent1"><span class="glyph">●</span>The patient experiences severe and constant pain at rest</p><p class="bulletIndent1"><span class="glyph">●</span>There is evidence of tissue damage such as amputation at or above the ankles of both extremities, or amputation of all digits of two or more extremities, and evidence of persistent widespread or deep ulceration involving two or more extremities</p><p class="bulletIndent1"><span class="glyph">●</span>Whole person impairment (100 percent)</p><p></p><p class="headingAnchor" id="H909629795"><span class="h1">DISABILITY</span><span class="headingEndMark"> — </span>Patients applying for disability with the Social Security Administration of the United States must meet the requirement for cardiovascular impairment [<a href="#rid37">37</a>]. To qualify, the patient must demonstrate the presence of a body system impairment severe enough to prevent gainful activity. The impairment is expected to last for a continuous period of at least 12 months. </p><p>For patients with intermittent claudication, one of the following must also be present:</p><p class="bulletIndent1"><span class="glyph">●</span>Resting ankle/brachial systolic blood pressure ratio of &lt;0.5</p><p class="bulletIndent1"><span class="glyph">●</span>Decrease in systolic blood pressure at the ankle on exercise of 50 percent or more from pre-exercise level and requiring ≥10 minutes to return to pre-exercise level</p><p class="bulletIndent1"><span class="glyph">●</span>Resting toe systolic pressure of &lt;30 mmHg</p><p class="bulletIndent1"><span class="glyph">●</span>Resting toe/brachial index &lt;0.4</p><p></p><p>For patients with extremity amputation (any cause), one of the following is required [<a href="#rid38">38</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Both hands</p><p class="bulletIndent1"><span class="glyph">●</span>One or both lower extremities at or above the tarsal region, with stump complications resulting in medical inability to use a prosthetic device to ambulate effectively</p><p class="bulletIndent1"><span class="glyph">●</span>One hand and one lower extremity at or above the tarsal region, with inability to ambulate effectively</p><p class="bulletIndent1"><span class="glyph">●</span>Hemipelvectomy or hip disarticulation</p><p></p><p>For patients with chronic venous disease, incompetence or obstruction of the deep venous system and one of the following must be present [<a href="#rid37">37</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Extensive brawny edema involving at least two-thirds of the leg between the ankle and knee or the distal one-third of the lower extremity between the ankle and hip</p><p class="bulletIndent1"><span class="glyph">●</span>Superficial varicosities, stasis dermatitis, and either recurrent ulceration or persistent ulceration that has not healed following at least three months of prescribed treatment</p><p></p><p class="headingAnchor" id="H758635355"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/117201.html" rel="external">"Society guideline links: Occlusive carotid, aortic, renal, mesenteric, and peripheral atherosclerotic disease"</a> and  <a class="medical medical_society_guidelines" href="/z/d/html/118637.html" rel="external">"Society guideline links: Acute extremity ischemia"</a>.)</p><p class="headingAnchor" id="H909629154"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span>Treatment options for lower extremity revascularization must take into consideration the urgency, duration, and severity of ischemia and the risk of the intervention relative to the patient's medical condition versus the expected improvement in the patient's clinical condition (eg, decreased pain, ulcer healing) and the durability of the intervention in the context of the patient's life expectancy. Grading the symptoms of peripheral artery disease and the anatomic lesions responsible for these symptoms provides an objective measure by which to follow patients clinically and, importantly, provides consistency when comparing interventional strategies in clinical studies. (See <a class="local">'Introduction'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The Rutherford and Fontaine symptom scales have traditionally been the most widely used classifications for chronic lower extremity ischemia. These have largely been replaced by an updated threatened limb classification system, put forth by the Society for Vascular Surgery (SVS) in 2014 to stratify the threat to limb caused by a spectrum of wounds, ischemia, and foot infection (WIfI), in part to reflect the global, epidemic rise in the prevalence of diabetes and diabetic foot ulcers. WIfI clinically predicts major limb amputation rates, wound healing, intensity of care, and costs of care.</p><p></p><p class="bulletIndent1">A Rutherford scale for acute limb ischemia is a separate and distinct scale from those applied to chronic limb ischemia. (See <a class="local">'Symptom classification'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Arterial lesions are classified anatomically by Trans-Atlantic Inter-Society Consensus (TASC II) as Type A, B, C, or D based upon the overall success rates of treating the lesion using endovascular or surgical means. Most patients with peripheral artery disease have more than one lesion, at more than one level, so the classification scheme is limited in focusing on singular patterns. TASC II Type A lesions represent simpler, focal lesions of the iliac, femoral, and popliteal arteries, while Type D lesions represent complex, long-segment lesions. Type B and Type C lesions are intermediate lesions. A classification system for the tibial vessels had been proposed but has not been validated. The Global Guidelines Committee has proposed a new classification system for chronic limb-threatening ischemia, the Global Limb Anatomic Staging System (ie, GLASS) for grading femoropopliteal and infrapopliteal disease. The GLASS classification remains to be validated. (See <a class="local">'TASC classification'</a> above and <a class="local">'GLASS classification'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>For patients who continue to suffer symptoms related to peripheral artery disease, impairment and disability may need to be quantified for insurance purposes or in order to qualify for disability. (See <a class="local">'Lower extremity impairment'</a> above and <a class="local">'Disability'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Norgren L, Hiatt WR, Dormandy JA, et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg 2007; 45 Suppl S:S5.</a></li><li><a class="nounderline abstract_t">Conte MS, Bradbury AW, Kolh P, et al. Global vascular guidelines on the management of chronic limb-threatening ischemia. J Vasc Surg 2019; 69:3S.</a></li><li><a class="nounderline abstract_t">Morris DR, Singh TP, Moxon JV, et al. Assessment and validation of a novel angiographic scoring system for peripheral artery disease. Br J Surg 2017; 104:544.</a></li><li><a class="nounderline abstract_t">Bradbury AW, Adam DJ, Bell J, et al. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: A description of the severity and extent of disease using the Bollinger angiogram scoring method and the TransAtlantic Inter-Society Consensus II classification. J Vasc Surg 2010; 51:32S.</a></li><li><a class="nounderline abstract_t">Jaff MR, White CJ, Hiatt WR, et al. An update on methods for revascularization and expansion of the TASC lesion classification to include below-the-knee arteries: A supplement to the inter-society consensus for the management of peripheral arterial disease (TASC II): The TASC steering committee. Catheter Cardiovasc Interv 2015; 86:611.</a></li><li><a class="nounderline abstract_t">Antoniou GA, Ibrahim R, Ahmad N, Torella F. Commentary: TASC II Anatomic Classification for Infrapopliteal Arterial Disease: A Framework for Clinical Practice and Future Research. J Endovasc Ther 2015; 22:678.</a></li><li><a class="nounderline abstract_t">Bollinger A, Breddin K, Hess H, et al. Semiquantitative assessment of lower limb atherosclerosis from routine angiographic images. Atherosclerosis 1981; 38:339.</a></li><li><a class="nounderline abstract_t">Graziani L, Silvestro A, Bertone V, et al. Vascular involvement in diabetic subjects with ischemic foot ulcer: a new morphologic categorization of disease severity. Eur J Vasc Endovasc Surg 2007; 33:453.</a></li><li><a class="nounderline abstract_t">Jude EB, Oyibo SO, Chalmers N, Boulton AJ. Peripheral arterial disease in diabetic and nondiabetic patients: a comparison of severity and outcome. Diabetes Care 2001; 24:1433.</a></li><li><a class="nounderline abstract_t">Rutherford RB, Baker JD, Ernst C, et al. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg 1997; 26:517.</a></li><li><a class="nounderline abstract_t">FONTAINE R, KIM M, KIENY R. [Surgical treatment of peripheral circulation disorders]. Helv Chir Acta 1954; 21:499.</a></li><li><a class="nounderline abstract_t">Zhan LX, Branco BC, Armstrong DG, Mills JL Sr. The Society for Vascular Surgery lower extremity threatened limb classification system based on Wound, Ischemia, and foot Infection (WIfI) correlates with risk of major amputation and time to wound healing. J Vasc Surg 2015; 61:939.</a></li><li><a class="nounderline abstract_t">van Reijen NS, Ponchant K, Ubbink DT, Koelemay MJW. Editor's Choice - The Prognostic Value of the WIfI Classification in Patients with Chronic Limb Threatening Ischaemia: A Systematic Review and Meta-Analysis. Eur J Vasc Endovasc Surg 2019; 58:362.</a></li><li><a class="nounderline abstract_t">Darling JD, McCallum JC, Soden PA, et al. Predictive ability of the Society for Vascular Surgery Wound, Ischemia, and foot Infection (WIfI) classification system following infrapopliteal endovascular interventions for critical limb ischemia. J Vasc Surg 2016; 64:616.</a></li><li><a class="nounderline abstract_t">Beropoulis E, Stavroulakis K, Schwindt A, et al. Validation of the Wound, Ischemia, foot Infection (WIfI) classification system in nondiabetic patients treated by endovascular means for critical limb ischemia. J Vasc Surg 2016; 64:95.</a></li><li><a class="nounderline abstract_t">Cull DL, Manos G, Hartley MC, et al. An early validation of the Society for Vascular Surgery lower extremity threatened limb classification system. J Vasc Surg 2014; 60:1535.</a></li><li><a class="nounderline abstract_t">Mills JL Sr, Conte MS, Armstrong DG, et al. The Society for Vascular Surgery Lower Extremity Threatened Limb Classification System: risk stratification based on wound, ischemia, and foot infection (WIfI). J Vasc Surg 2014; 59:220.</a></li><li><a class="nounderline abstract_t">Mills JL Sr. The application of the Society for Vascular Surgery Wound, Ischemia, and foot Infection (WIfI) classification to stratify amputation risk. J Vasc Surg 2017; 65:591.</a></li><li><a class="nounderline abstract_t">Robinson WP, Loretz L, Hanesian C, et al. Society for Vascular Surgery Wound, Ischemia, foot Infection (WIfI) score correlates with the intensity of multimodal limb treatment and patient-centered outcomes in patients with threatened limbs managed in a limb preservation center. J Vasc Surg 2017; 66:488.</a></li><li class="breakAll">http://download.journals.elsevierhealth.com/pdfs/journals/0741-5214/PIIS0741521413015152.pdf (Accessed on January 23, 2014).</li><li class="breakAll">https://itunes.apple.com/app/id1014644425 (Accessed on February 02, 2018).</li><li class="breakAll">Armstrong DG, Mills JL. Juggling risk to reduce amputations: The three-ring circus of infection, ischemia and tissue loss-dominant conditions, Wound Medicine 2013; 1:13. http://www.sciencedirect.com/science/article/pii/S2213909513000037.</li><li><a class="nounderline abstract_t">Darling JD, McCallum JC, Soden PA, et al. Predictive ability of the Society for Vascular Surgery Wound, Ischemia, and foot Infection (WIfI) classification system after first-time lower extremity revascularizations. J Vasc Surg 2017; 65:695.</a></li><li><a class="nounderline abstract_t">Kobayashi N, Hirano K, Yamawaki M, et al. Characteristics and clinical outcomes of repeat endovascular therapy after infrapopliteal balloon angioplasty in patients with critical limb ischemia. Catheter Cardiovasc Interv 2018; 91:505.</a></li><li><a class="nounderline abstract_t">Hicks CW, Canner JK, Mathioudakis N, et al. The Society for Vascular Surgery Wound, Ischemia, and foot Infection (WIfI) classification independently predicts wound healing in diabetic foot ulcers. J Vasc Surg 2018; 68:1096.</a></li><li><a class="nounderline abstract_t">Okazaki J, Matsuda D, Tanaka K, et al. Analysis of wound healing time and wound-free period as outcomes after surgical and endovascular revascularization for critical lower limb ischemia. J Vasc Surg 2018; 67:817.</a></li><li><a class="nounderline abstract_t">Iida O, Takahara M, Soga Y, et al. Three-Year Outcomes of Surgical Versus Endovascular Revascularization for Critical Limb Ischemia: The SPINACH Study (Surgical Reconstruction Versus Peripheral Intervention in Patients With Critical Limb Ischemia). Circ Cardiovasc Interv 2017; 10:e005531.</a></li><li><a class="nounderline abstract_t">Ramanan B, Ahmed A, Wu B, et al. Determinants of midterm functional outcomes, wound healing, and resources used in a hospital-based limb preservation program. J Vasc Surg 2017; 66:1765.</a></li><li><a class="nounderline abstract_t">Leithead C, Novak Z, Spangler E, et al. Importance of postprocedural Wound, Ischemia, and foot Infection (WIfI) restaging in predicting limb salvage. J Vasc Surg 2018; 67:498.</a></li><li><a class="nounderline abstract_t">Hicks CW, Canner JK, Karagozlu H, et al. The Society for Vascular Surgery Wound, Ischemia, and foot Infection (WIfI) classification system correlates with cost of care for diabetic foot ulcers treated in a multidisciplinary setting. J Vasc Surg 2018; 67:1455.</a></li><li><a class="nounderline abstract_t">Rutherford RB. Acute limb ischemia: Clinical assessment and standards for reporting. Semin Vasc Surg 1992; 5:4.</a></li><li><a class="nounderline abstract_t">Katzen BT. Clinical diagnosis and prognosis of acute limb ischemia. Rev Cardiovasc Med 2002; 3 Suppl 2:S2.</a></li><li><a class="nounderline abstract_t">Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation 2006; 113:e463.</a></li><li><a class="nounderline abstract_t">Spieler EA, Barth PS, Burton JF Jr, et al. Recommendations to guide revision of the Guides to the Evaluation of Permanent Impairment. American Medical Association. JAMA 2000; 283:519.</a></li><li class="breakAll">Rondinelli, R. Guides to the Evaluation of Permanent Impairment, Sixth Edition, American Medical Association, Chicago 2008.</li><li><a class="nounderline abstract_t">Cocchiarella L, Turk MA, Andersson G. Improving the evaluation of permanent impairment. JAMA 2000; 283:532.</a></li><li class="breakAll">http://www.ssa.gov/disability/professionals/bluebook/4.00-Cardiovascular-Adult.htm (Accessed on October 04, 2011).</li><li class="breakAll">http://www.ssa.gov/disability/professionals/bluebook/1.00-Musculoskeletal-Adult.htm (Accessed on October 04, 2011).</li></ol></div><div id="topicVersionRevision">Topic 16740 Version 22.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17223489" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31159978" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Global vascular guidelines on the management of chronic limb-threatening ischemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28140457" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Assessment and validation of a novel angiographic scoring system for peripheral artery disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20435260" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: A description of the severity and extent of disease using the Bollinger angiogram scoring method and the TransAtlantic Inter-Society Consensus II classification.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26256456" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : An update on methods for revascularization and expansion of the TASC lesion classification to include below-the-knee arteries: A supplement to the inter-society consensus for the management of peripheral arterial disease (TASC II): The TASC steering committee.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26239797" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Commentary: TASC II Anatomic Classification for Infrapopliteal Arterial Disease: A Framework for Clinical Practice and Future Research.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7225173" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Semiquantitative assessment of lower limb atherosclerosis from routine angiographic images.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17196848" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Vascular involvement in diabetic subjects with ischemic foot ulcer: a new morphologic categorization of disease severity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11473082" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Peripheral arterial disease in diabetic and nondiabetic patients: a comparison of severity and outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9308598" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Recommended standards for reports dealing with lower extremity ischemia: revised version.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14366554" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : [Surgical treatment of peripheral circulation disorders].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25656592" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : The Society for Vascular Surgery lower extremity threatened limb classification system based on Wound, Ischemia, and foot Infection (WIfI) correlates with risk of major amputation and time to wound healing.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31230866" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Editor's Choice - The Prognostic Value of the WIfI Classification in Patients with Chronic Limb Threatening Ischaemia: A Systematic Review and Meta-Analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27380993" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Predictive ability of the Society for Vascular Surgery Wound, Ischemia, and foot Infection (WIfI) classification system following infrapopliteal endovascular interventions for critical limb ischemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26994958" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Validation of the Wound, Ischemia, foot Infection (WIfI) classification system in nondiabetic patients treated by endovascular means for critical limb ischemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25282695" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : An early validation of the Society for Vascular Surgery lower extremity threatened limb classification system.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24126108" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : The Society for Vascular Surgery Lower Extremity Threatened Limb Classification System: risk stratification based on wound, ischemia, and foot infection (WIfI).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28236912" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : The application of the Society for Vascular Surgery Wound, Ischemia, and foot Infection (WIfI) classification to stratify amputation risk.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28410924" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Society for Vascular Surgery Wound, Ischemia, foot Infection (WIfI) score correlates with the intensity of multimodal limb treatment and patient-centered outcomes in patients with threatened limbs managed in a limb preservation center.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28410924" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Society for Vascular Surgery Wound, Ischemia, foot Infection (WIfI) score correlates with the intensity of multimodal limb treatment and patient-centered outcomes in patients with threatened limbs managed in a limb preservation center.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28410924" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Society for Vascular Surgery Wound, Ischemia, foot Infection (WIfI) score correlates with the intensity of multimodal limb treatment and patient-centered outcomes in patients with threatened limbs managed in a limb preservation center.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28410924" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Society for Vascular Surgery Wound, Ischemia, foot Infection (WIfI) score correlates with the intensity of multimodal limb treatment and patient-centered outcomes in patients with threatened limbs managed in a limb preservation center.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28073665" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Predictive ability of the Society for Vascular Surgery Wound, Ischemia, and foot Infection (WIfI) classification system after first-time lower extremity revascularizations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28799724" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Characteristics and clinical outcomes of repeat endovascular therapy after infrapopliteal balloon angioplasty in patients with critical limb ischemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29622357" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : The Society for Vascular Surgery Wound, Ischemia, and foot Infection (WIfI) classification independently predicts wound healing in diabetic foot ulcers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29032905" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Analysis of wound healing time and wound-free period as outcomes after surgical and endovascular revascularization for critical lower limb ischemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29246911" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Three-Year Outcomes of Surgical Versus Endovascular Revascularization for Critical Limb Ischemia: The SPINACH Study (Surgical Reconstruction Versus Peripheral Intervention in Patients With Critical Limb Ischemia).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28823866" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Determinants of midterm functional outcomes, wound healing, and resources used in a hospital-based limb preservation program.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28943004" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Importance of postprocedural Wound, Ischemia, and foot Infection (WIfI) restaging in predicting limb salvage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29248237" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : The Society for Vascular Surgery Wound, Ischemia, and foot Infection (WIfI) classification system correlates with cost of care for diabetic foot ulcers treated in a multidisciplinary setting.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Acute limb ischemia: Clinical assessment and standards for reporting</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12556737" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Clinical diagnosis and prognosis of acute limb ischemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16549646" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10659879" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Recommendations to guide revision of the Guides to the Evaluation of Permanent Impairment. American Medical Association.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10659879" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Recommendations to guide revision of the Guides to the Evaluation of Permanent Impairment. American Medical Association.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10659882" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Improving the evaluation of permanent impairment.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
